Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Adenosine antagonists claimed by Fujisawa

Feb. 26, 1997

Unexpected phase I results reported for DuP-532

Feb. 25, 1997

Deltibant in SIRS

Feb. 21, 1997

Cylexin enters clinical trials in newborns

Feb. 21, 1997

Novel vasopressin antagonists from Fujisawa

Feb. 21, 1997

Biorex discloses antiischemic agents

Feb. 20, 1997

Zambon discloses ACE/NEP inhibitors

Feb. 20, 1997

Antiarrhythmic agents from Merck & Co.

Feb. 19, 1997

German launch for ACE inhibitor

Feb. 17, 1997

Approval anticipated for TMR using Heart Laser

Feb. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...